Literature DB >> 18414105

Evaluation of a modified protocol for selective laser trabeculoplasty.

Mathew K George1, John W Emerson, Sameer A Cheema, Robert McGlynn, Bryce A Ford, James F Martone, Milton Bruce Shields, Martin Wand.   

Abstract

PURPOSE: To compare the intraocular pressure (IOP) response to a modified protocol for selective laser trabeculoplasty (SLT) to standard protocols for SLT and argon laser trabeculoplasty (ALT).
MATERIALS AND METHODS: A retrospective study of 318 eyes of 284 patients diagnosed with either primary open angle, pigmentary or pseudoexfoliation glaucoma who underwent laser trabeculoplasty from September 1997 to September 2005. One hundred and two patients, who underwent a modified SLT protocol with 100 overlapping laser spots over 180 degrees of trabecular meshwork were compared with 89 patients who received SLT with 100 nonoverlapping spots over 360 degrees and another 127 patients who received ALT with 50 spots over 180 degrees. IOPs were measured at baseline and postoperatively at 1 hour, 6 weeks, 4 months, and 14 months. Regression models, based on the observed data, were used to predict the fall in IOP in the 3 groups, controlling for differences in baseline pressure.
RESULTS: The IOP response to overlapping SLT was significantly worse than to nonoverlapping SLT or ALT, both of which had similar responses. Baseline IOP was the only preoperative factor that predicted response to ALT (P<0.0001) and nonoverlapping SLT (P=0.0019) at all follow-up times. There were no statistically significant predictive factors for IOP reduction in the overlapping SLT group.
CONCLUSIONS: Overlapping application of SLT results in a poorer IOP response compared with ALT and nonoverlapping SLT.

Entities:  

Mesh:

Year:  2008        PMID: 18414105     DOI: 10.1097/IJG.0b013e3181567890

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  13 in total

1.  [Laser trabeculoplasty: therapeutic options and adverse effects].

Authors:  T Wacker; S Eckert
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

Review 2.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

3.  Selective laser trabeculoplasty.

Authors:  Jing-Ming Shi; Song-Bai Jia
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

4.  Clinical results of selective laser trabeculoplasty in silicone oil-induced secondary glaucoma.

Authors:  Miaomiao Zhang; Bin Li; Jianrong Wang; Wei Liu; Yan Sun; Xinyi Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-27       Impact factor: 3.117

5.  Intraocular pressure reduction after initial failure of selective laser trabeculoplasty (SLT).

Authors:  Marcelo Ayala
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-21       Impact factor: 3.117

6.  [Effectiveness of selective laser trabeculoplasty in patients with insufficient control of intraocular pressure despite maximum tolerated medical therapy].

Authors:  C Hirn; S A Zweifel; M Töteberg-Harms; J Funk
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

Review 7.  A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".

Authors:  Tomislav Sarenac; Anela Bečić Turkanović; Peter Ferme; Tomaž Gračner
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

8.  Predictive factors of success in selective laser trabeculoplasty (SLT) treatment.

Authors:  Marcelo Ayala; Enping Chen
Journal:  Clin Ophthalmol       Date:  2011-05-09

9.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

10.  Selective laser trabeculoplasty: Does energy dosage predict response?

Authors:  Larissa Habib; James Lin; Tamara Berezina; Bart Holland; Robert D Fechtner; Albert S Khouri
Journal:  Oman J Ophthalmol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.